Cargando…

Risk‐adapted stereotactic body radiotherapy for patients with cervical spinal metastases

Owing to the complex anatomical structure and biomechanics, the current standard palliative treatments for cervical spinal metastases are associated with a high risk of recurrence and complications. Stereotactic body radiotherapy (SBRT) can provide radical dose to tumors while protecting normal orga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huan‐Huan, Tian, Shou‐Sen, Yang, Jia‐Min, Sun, Bing‐Sheng, Chen, Ying, Song, Yong‐Chun, Dong, Yang, Wang, Jing‐Sheng, Yuan, Zhi‐Yong, Cui, Yao‐Li, Meng, Mao‐Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746029/ https://www.ncbi.nlm.nih.gov/pubmed/36056609 http://dx.doi.org/10.1111/cas.15559

Ejemplares similares

Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases
por: Yuan, Zhi-Yong, et al.
Publicado: (2014)

Improving accuracy for stereotactic body radiotherapy treatments of spinal metastases
por: Rijken, James, et al.
Publicado: (2018)

Clinical outcomes of stereotactic body radiotherapy for spinal metastases from hepatocellular carcinoma
por: Lee, Eonju, et al.
Publicado: (2015)

The impact of radiosensitivity on clinical outcomes of spinal metastases treated with stereotactic body radiotherapy
por: Guo, Lanlan, et al.
Publicado: (2023)

Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer
por: Meng, Mao‐Bin, et al.
Publicado: (2019)

Stereotactic Radiotherapy for Cervical Spinal Intramedullary Metastasis and Multiple Brain Metastases: A Case Report
por: Mori, Yoshimasa, et al.
Publicado: (2016)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2022)

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
por: Lindsay, Adam D., et al.
Publicado: (2018)

Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
por: Gutiérrez, Enrique, et al.
Publicado: (2021)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
por: Gong, Yining, et al.
Publicado: (2019)

Optimized workflow to minimise intra-fractional motion during stereotactic body radiotherapy of spinal metastases
por: vanNiekerk, W.M., et al.
Publicado: (2022)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

MRI feature-based radiomics models to predict treatment outcome after stereotactic body radiotherapy for spinal metastases
por: Chen, Yongye, et al.
Publicado: (2023)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
por: Berkovic, Patrick, et al.
Publicado: (2020)

Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases
por: Lindberg, Sara, et al.
Publicado: (2022)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
por: Ricco, Anthony, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy for Spinal Metastases: Clinical Experience in 134 Cases From a Single Japanese Institution
por: Ito, Kei, et al.
Publicado: (2018)

Intrafractional motion in stereotactic body radiotherapy of spinal metastases utilizing cone beam computed tomography image guidance
por: Graadal Svestad, Jørund, et al.
Publicado: (2019)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases
por: Colaco, Rovel J, et al.
Publicado: (2016)

Stereotactic body radiotherapy with a single isocentre for multiple pulmonary metastases
por: Nakamura, Ryuji, et al.
Publicado: (2020)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
por: Wang, Shih-Chang, et al.
Publicado: (2020)

Efficacy and safety of stereotactic body radiotherapy for painful bone metastases: Evidence from randomized controlled trials
por: Wang, Zilan, et al.
Publicado: (2022)

Comparison of stereotactic body radiotherapy versus metastasectomy outcomes in patients with pulmonary metastases
por: Lee, Yun Hee, et al.
Publicado: (2018)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
por: Yeung, Rosanna, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
por: König, Laila, et al.
Publicado: (2020)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

Quantifying the Changes in the Tumour Vascular Micro-environment in Spinal Metastases Treated with Stereotactic Body Radiotherapy - A Single Arm Prospective Study
por: Vellayappan, Balamurugan, et al.
Publicado: (2022)

Examining the use of abdominal compression in stereotactic body radiotherapy for liver metastases – a single center’s experience of 10 years
por: Sen, Cenk Ahmet
Publicado: (2022)

Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma
por: Feng, Xiao-Yao, et al.
Publicado: (2022)

30 GY IN 4 STEREOTACTIC BODY RADIOTHERAPY (SBRT) FRACTIONS FOR COMPLEX SPINAL METASTASES: MATURE OUTCOMES SUPPORTING THIS NOVEL REGIMEN
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial
por: Sprave, Tanja, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases
por: Pontoriero, Antonio, et al.
Publicado: (2020)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Efficacy and Dose-Response Relationship of Stereotactic Body Radiotherapy for Abdominal Lymph Node Metastases from Hepatocellular Carcinoma
por: Wang, Yuting, et al.
Publicado: (2023)

Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study
por: Aoki, Masahiko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_24tn77fnu7r6fl5h27ig1jen16